Skip to main content

Advertisement

SpringerLink
Log in

Surface plasmon resonance imaging in arrays coupled with mass spectrometry (SUPRA–MS): proof of concept of on-chip characterization of a potential breast cancer marker in human plasma

  • Original Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

Protein biomarker discovery and validation are crucial for diagnosis, prognosis, and theranostics of human pathologies; “omics” approaches bring new insights in this field. In particular, the combination of immuno-sensors in array format with mass spectrometry efficiently extends the classical immunoassay format and includes molecular characterization. Here, we coupled surface plasmon resonance imaging (SPRi) with MALDI-TOF mass spectrometry in a hyphenated technique which enables multiplexed quantification of binding by SPRi and molecular characterization of interacting partners by subsequent MS analysis. This adds specificity, because MS enables differentiation of molecules that are difficult to distinguish by use of antibodies, for example truncation variants or protein isoforms. Proof of concept was established for detection, identification, and characterization of a potential breast cancer marker, the LAG3 protein, at ~1 μg mL−1, added to human plasma. The analytical performance of this new method, dubbed “SUPRA-MS”, was established, particularly its specificity (S/N > 10) and reliability (100 % LAG3 identification with high significant mascot score >87.9). The adjusted format for rapid, collective, and automated on-chip MALDI-MS analysis is robust at the femtomole level and has numerous potential applications in proteomics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. El Mouedden M, Vandermeeren M, Meert T, Mercken M (2005) J Neurosci Meth 145:97–105

    Article  Google Scholar 

  2. Jain N, Kesimer M, Hoyer JD, Calikoglu AS (2011) J Diabetes Complications 25:14–8

    Article  Google Scholar 

  3. Sparbier K, Wenzel T, Dihazi H, Blaschke S, Müller G-A, Deelder A, Flad T, Kostrzewa M (2009) Proteomics 9:1442–1450

    Article  CAS  Google Scholar 

  4. Trenchevska O, Kamcheva E, Nedelkov D (2010) J Proteome Res 9:5969–5973

    Article  CAS  Google Scholar 

  5. Lopez M-F, Rezai T, Sarracino DA, Prakash A, Krastins B, Athanas M, Singh R-J, Barnidge D-R, Oran P, Borges C, Nelson R-W (2010) Clin Chem 56:281–290

    Article  CAS  Google Scholar 

  6. Anderson N-L, Anderson N-G, Haines L-R, Hardie D-B, Olafson R-W, Pearson T-W (2004) J Proteome Res 3:235–244

    Article  CAS  Google Scholar 

  7. Gavin I-M, Kukhtin A, Glesne D, Schabacker D, Chandler D-P (2005) Biotechniques 39:99–107

    Article  CAS  Google Scholar 

  8. Jiang J, Parker C-E, Fuller J-R, Kawula T-H, Borchers C-H (2007) Anal Chim Acta 605:70–79

    Article  CAS  Google Scholar 

  9. Darii E, Lebeau D, Papin N, Rubina A-Y, Stomakhin A, Tost J, Sauer S, Savvateeva E, Dementieva E, Zasedatelev A, Makarov A-A, Gut I-G (2009) New Biotechnol 25:404–416

    Article  CAS  Google Scholar 

  10. Razavi M, Pope M-E, Soste M-V, Eyford B-A, Jackson A-M, Anderson N-L, Pearson TW (2011) J Immunol Methods 364:50–64

    Article  CAS  Google Scholar 

  11. Yan H, Ahmad-Tajudin A, Bengtsson M, Xiao S-J, Laurell T, Ekstrom S (2011) Anal Chem 83:4942–48

    Article  CAS  Google Scholar 

  12. Natsume T, Nakayama H, Jansson S, Isobe T, Takio K, Mikoshiba K (2000) Anal Chem 72:4193–4198

    Article  CAS  Google Scholar 

  13. Catimel B, Rothacker J, Catime J, Faux M, Ross J, Connolly L, Clippingdale A, Burges A-W, Nice E (2005) J Proteome Res 4:1646–1656

    Article  CAS  Google Scholar 

  14. Larsericsdotter H, Jansson O, Zhukov A, Areskou D, Oscarsson S, Buijs J (2006) Proteomics 6:2355–2364

    Article  CAS  Google Scholar 

  15. Stigter E-C-A, de Jong G-J, van Bennekom W-P (2009) Biosens Bioelectron 24:2184–2190

    Article  CAS  Google Scholar 

  16. Nedelkov D, Nelson R-W (2000) J Mol Recognit 13:140–145

    Article  CAS  Google Scholar 

  17. Nedelkov D, Tubbs K-A, Nelson R-W (2006) Electrophoresis 27:3671–3675

    Article  CAS  Google Scholar 

  18. Nedelkov D (2007) Anal Chem 79:5987–5990

    Article  CAS  Google Scholar 

  19. Treitz G, Gronewold T-M-A, Quandt E, Zabe-Kühn M (2008) Biosens Bioelectron 23:1496–1502

    Article  CAS  Google Scholar 

  20. Situ C, Buijs J, Mooney MH, Elliott C-T (2010) Trends Anal Chem 29:1305–131

    Article  CAS  Google Scholar 

  21. Grote J, Dankbar N, Gedig E, Koenig S (2005) Anal Chem 77:1157–1162

    Article  CAS  Google Scholar 

  22. Kim Y-E, Yi S-Y, Lee C-S, Jung Y, Chung B-H (2011) Analyst. doi:10.1039/c1an15659d

  23. Boireau W, Rouleau A, Lucchi G, Ducoroy P (2009) Biosens Bioelectron 24:1121–1127

    Article  CAS  Google Scholar 

  24. Bellon S, Buchmann W, Gonnet F, Jarroux N, Anger-Leroy M, Guillonneau F, Daniel R (2009) Anal Chem 81:7695–702

    Article  CAS  Google Scholar 

  25. Springer T, Piliarik M, Homola J (2010) Anal Bioanal Chem 398:1955–1961

    Article  CAS  Google Scholar 

  26. Vaisocherova H, Yang W, Zhang Z, Cao ZQ, Cheng G, Piliarik M, Homola J, Jiang S-Y (2008) Anal Chem 80:7894–7901

    Article  CAS  Google Scholar 

  27. Anderson N-L, Razavi M, Pearson T-W, Kruppa G, Paape R, Suckau D (2011) J Proteome Res. doi:10.1021/pr201092v

  28. Moussaoui W, Jaulhac B, Hoffmann A-M, Ludes B, Kostrzewa M, Riegel P, Prévost G (2010) Clin Microbiol Infect 16:1631–1638

    Article  CAS  Google Scholar 

  29. Triebel F, Hacene K, Pichon MF (2006) Cancer Lett 235:147–153

    Article  CAS  Google Scholar 

  30. Kardous F, Rouleau A, Simon B, Yahiaoui R, Manceau J-F, Boireau W (2010) Biosens Bioelectron 26:1666–1671

    Article  CAS  Google Scholar 

  31. Kardous F, El Fissi L, Friedt J-M, Boireau W, Yahiaoui R, Manceau J-F, Ballandras S (2011) J Appl Phys 109(9). doi:10.1063/1.3576113

  32. Stenberg E, Persson B, Roos H, Urbaniczky C (1991) J Colloids Interface Sci 143:513–526

    Article  CAS  Google Scholar 

  33. Cazares L-H, Troyer D-A, Wang B, Drake R-R, Semmes O-J (2011) Anal Bioanal Chem 401:17–27

    Article  CAS  Google Scholar 

  34. Suckau D, Kohl J, Karwath G, Schneider K, Casaretto M, Bitter-Suermann D, Przybylski M (1990) PNAS 87:9848–9852

    Article  CAS  Google Scholar 

  35. Clemis EJ, Smith DS, Camenzind AG, Danell RM, Parker CE, Borchers CH (2012) Anal Chem 84(8):3514–22

    Article  CAS  Google Scholar 

  36. Anderson NL, Razavi M, Pearson TW, Kruppa G, Paape R, Suckau D (2012) J Proteome Res 11(3):1868–78

    Article  CAS  Google Scholar 

Download references

Acknowledgment

The authors thank other members of our laboratory for help and fruitful discussions. The authors would like to thank Dr Frédéric Triebel (from Immutep SA) for providing the A9H12/LAG3 model and the technological “Mimento platform” (Besançon, France). We are grateful to Bruker Daltonics, especially Y. Hebert for his technological support. This study was supported by grants from Horiba Scientific, the Ministry of Health and Research, the Conseil Regional de Bourgogne, and the Franche-Comté University. The authors thank Mr Philip Bastable, translator at Dijon Hospital, for proofreading.

Author information

Authors and Affiliations

  1. Institut FEMTO-ST, Université de Franche Comté, CLIPP, 25044, Besançon, France

    F. Remy-Martin, R. Zeggari, T. Leblois & W. Boireau

  2. SFR Santé STIC, CLIPP (Clinical-Innovation Proteomic platform), Université de Bourgogne, Centre Hospitalier Universitaire de Dijon, 21079, Dijon, France

    M. El Osta, G. Lucchi & P. Ducoroy

  3. Horiba Scientific, 91380, Chilly Mazarin, France

    F. Remy-Martin & S. Bellon

  4. Department of Micro-Nano Sciences & Systems, FEMTO-ST Institute, University of Franche-Comté, CLIPP (Clinical-Innovation Proteomic Platform), 32, Av. de l’Observatoire, 25044, Besançon Cedex, France

    W. Boireau

Authors
  1. F. Remy-Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. El Osta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Lucchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Zeggari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Leblois
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Bellon
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Ducoroy
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. W. Boireau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Boireau.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM. 1

(DOC 309 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Remy-Martin, F., El Osta, M., Lucchi, G. et al. Surface plasmon resonance imaging in arrays coupled with mass spectrometry (SUPRA–MS): proof of concept of on-chip characterization of a potential breast cancer marker in human plasma. Anal Bioanal Chem 404, 423–432 (2012). https://doi.org/10.1007/s00216-012-6130-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-012-6130-4

Keywords

Search

Navigation